Morning Breakouts

Latest California Healthline Stories

Other Ideas ‘Worth Considering’ Following Repeal of Employer-Sponsored Health Coverage Law, Opinion Piece States

Voters’ rejection of a state law (SB 2) that would have required some employers to provide employees with health insurance and a failed move in the state Legislature to increase taxes to finance health care programs could indicate that it is “time to move in the other direction,” columnist Daniel Weintraub writes in Sacramento Bee opinion piece.

Sanofi-Aventis Drug Effectively Aids and Maintains Weight Loss, Study Finds

Patients who took a high dose of rimonabant, a weight-loss medication manufactured by Sanofi-Aventis, lost an average of 19 pounds and maintained the weight loss, provided that they continued to take the treatment, according to a study presented on Tuesday at the American Heart Association annual conference, USA Today reports.

Los Angeles Times Looks at Financial Deals Involving Two Rural Ventura County Hospitals

The Los Angeles Times on Sunday examined how Ojai Valley Community Hospital and Santa Paula Memorial Hospital are “[b]ucking a trend toward larger and fewer hospitals” in the state through financial deals “that could ensure their existence for years to come.”

CDC Announces Distribution Plan for Remaining Flu Vaccine Doses

CDC officials on Tuesday announced a flu vaccine distribution plan that directs states to allocate the nation’s remaining 10.3 million doses based on states’ populations of high-risk residents and the number of doses states have received amid a nationwide vaccine shortage, the Washington Post reports.

Express Scripts To Launch Nationwide Generic Medication Discount Program for Low-Income U.S. Residents

Missouri-based Express Scripts, one of the largest U.S. pharmacy benefit managers, on Monday announced plans to launch a new program this week that will offer discounts on dozens of generic medications to low-income U.S. residents nationwide, the AP/Las Vegas Sun reports.

Merck Under Investigation by Department of Justice, Securities and Exchange Commission Over Actions on Vioxx

Merck in documents filed with the Securities and Exchange Commission on Monday reported that the Department of Justice has launched a criminal investigation into company actions related to the arthritis medication Vioxx and that SEC also has begun an informal inquiry, the Wall Street Journal reports.